XML 45 R30.htm IDEA: XBRL DOCUMENT
v3.23.2

Supplemental Equity and Accumulated Other Comprehensive Income (loss) Information (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2023
Notes Tables |
Schedule of each component of other comprehensive income (loss) | Changes in accumulated other comprehensive income (loss) attributable to Bio-Techne, net of tax, are summarized as follows (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Unrealized | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Gains | ​ | Foreign | ​ | ​ | ​
​ | ​ | (Losses) on | ​ | Currency | ​ | ​ | ​
​ | ​ | Derivative | ​ | Translation | ​ | ​ | ​
​ |  | Instruments |  | Adjustments |  | Total
Balance June 30, 2020(3) | ​ | $ | (13,253) | ​ | $ | (83,946) | ​ | $ | (97,199)
Other comprehensive income (loss) before reclassifications | ​ |  | 100 | ​ |  | 32,848 | ​ |  | 32,948
Reclassification from loss on derivatives to interest expense, net of taxes(1) | ​ | ​ | 6,960 | ​ |  | — | ​ | ​ | 6,960
Balance June 30, 2021(3) | ​ | $ | (6,193) | ​ | $ | (51,098) | ​ | $ | (57,291)
Other comprehensive income (loss) before reclassifications, net of taxes, attributable to Bio-Techne(2) | ​ |  | 9,403 | ​ |  | (32,171) | ​ |  | (22,768)
Reclassification from loss on derivatives to interest expense, net of taxes, attributable to Bio-Techne(1) | ​ |  | 4,859 | ​ | ​ | — | ​ |  | 4,859
Balance as of June 30, 2022 | ​ | $ | 8,069 | ​ | $ | (83,269) | ​ | $ | (75,200)
Other comprehensive income (loss) before reclassifications, net of taxes, attributable to Bio-Techne(2) | ​ |  | 8,246 | ​ |  | 4,191 | ​ |  | 12,437
Reclassification from (gain) loss on derivatives to interest expense, net of taxes, attributable to Bio-Techne(1) | ​ |  | (3,453) | ​ | ​ | — | ​ | ​ | (3,453)
Reclassification of cumulative translation adjustment for Eminence to non-operating income, net of taxes, attributable to Bio-Techne | ​ | ​ | — | ​ | ​ | 152 | ​ | ​ | 152
Balance as of June 30, 2023(2) | ​ | $ | 12,862 | ​ | $ | (78,926) | ​ | $ | (66,064)
(1) | Gains (losses) on the interest swap will be reclassified into interest expense as payments on the derivative agreement are made. The Company reclassified $4,526 to interest income and recorded a related tax expense of $1,073 during fiscal 2023. The Company reclassified $6,352 to interest expense and recorded a related tax benefit of $1,493 during fiscal 2022. The Company reclassified $8,598 to interest expense and $512 to non-operating income relating to variable interest payments that were probable not to occur for the fiscal year ended June 30, 2021. The Company also recorded a related tax benefit of $2,150 during fiscal 2021.
​
(2) | Other comprehensive income related to foreign currency translation adjustments in the table above includes the amount attributable to Bio-Techne and excludes the $33 and $70 attributable to the non-controlling interest in Eminence as of June 30, 2023, and June 30, 2022, respectively.
(3) | The Company had a net deferred tax liability of $3,995 and $2,480 as of June 30, 2023, and June 30, 2022, respectively, and a net deferred tax benefit of $1,908 as of June 30, 2021.

X
- Definition Tabular disclosure of the components of accumulated other comprehensive income (loss). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 14A -Publisher FASB -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20 + Details
Name: | us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration